Chapter 20 – Product Liability
“pure” or the “mixed” fashions described in Chapter 7. Third, it is not always clear
whether comparative principles apply to all theories of recovery or all types of
damage claims.
c. Comparative fault examples: Green (discussed below); Problem #13.
d. Green v. Ford Motor Co. (p. 587): The Supreme Court of Indiana holds that in a case
in which the plaintiff alleges that the defendant motor vehicle manufacturer
negligently failed to provide a “crashworthy” vehicle, Indiana’s comparative fault
law requires that evidence of the plaintiff’s own fault, which allegedly contributed to
either the causation of the accident or to the severity of his injuries, is to be compared
against the defendant’s degree of fault.
Points for Discussion: Ask what the crashworthiness doctrine contemplates and why
many jurisdictions have recognized it. (Because it is foreseeable that the vehicles
they produce may become involved in accidents, manufacturers should be expected
to take reasonable design steps to lessen the severity of injuries in those foreseeable
crashes.) Note that crashworthiness claims are really enhanced injury claims because
the plaintiffs who bring them are not arguing that the manufacturer’s defective design
caused the accident. Rather, the plaintiffs are arguing that once the accident
occurred, they experienced more severe injuries than they otherwise would have
suffered if the manufacturer had adopted a crashworthy design. In this case, how dis
the plaintiff’s own behavior enter in? (He may have been negligent in operating the
vehicle. Thus, he may have caused, or helped to cause, the accident. Obviously, he
would not have been injured at all, let alone more severely than he supposedly should
have been, if the accident hadn’t occurred.) Why does the court reject the plaintiff’s
argument that his behavior shouldn’t be compared against that of the defendant?
(Because the Indiana statute set forth a clear policy of comparing degrees of fault as
between plaintiffs and defendants, and was broad enough to contemplate, in
crashworthiness cases, plaintiffs’ behavior that either helped to cause the collision or
otherwise helped to increase the severity of the injuries experienced.)
4. Preemption and Regulatory Compliance
a. This was a new section added for the 14th edition. The 15th and 16th editions then
expanded the section with discussion of other relevant Supreme Court decisions (Riegel,
Wyeth, and Pliva; see below). the comparative merits of the preemption and regulatory
compliance defenses. Preemption, importantly, is conclusive: a plaintiff’s claim ends
completely if it is preempted. But whether preemption applies depends on the relevant
statute and its history. The regulatory compliance defense, meanwhile, is always
available to a compliant manufacturer. However, it is less likely to end a claim, and more
likely simply to weigh against it.
b. Note the text’s discussion of Levine, in which the Supreme Court held that FDA approval
of a drug does not automatically bar negligence claims based on defective design.
Emphasize how the statutory sections at issue in Riegel, the text case discussed below,
differed from those at issue in Levine. (There was a preemption provision in the former,
but not in the latter.) But then, as the text notes, the Court decided Pliva. Was Pliva, as
critics have alleged, simply an attempt to cut back on the effect of Levine?
c. Riegel v. Medtronic, Inc. (p. 590): The Supreme Court affirmed the lower courts’
holdings that the preemption provisions in the Medical Device Amendments (MDA) to
the Food, Drug, and Cosmetic Act barred state common-law product liability claims
regarding medical devices.
Points for Discussion: Justice Scalia says Congress would not have given a state jury
greater power than a state legislature or regulatory authority. But is that really where the
20-13
© 2016 by McGraw-Hill Education. This is proprietary material solely for authorized instructor use. Not authorized for sale or distribution in any
manner. This document may not be copied, scanned, duplicated, forwarded, distributed, or posted on a website, in whole or part.